Prot #KT-US-471-0119: A Phase 1/2 Open-label, Multicenter Study of Lenzilumab and Axicabtagene Ciloleucel in Subjects with Relapsed or Refractory Large B-cell Lymphoma (ZUMA-19)
- Karmali, Reem (PD/PI)
Project: Research project
Project: Research project